1355034-75-1

Upstream product

• 168253-07-4 (2R,3R,4R,5S,6S)-3,4,5-Tris-benzyloxy-2-benzyloxymethyl-6-ethynyl-tetrahydro-pyran 
• 104-81-4 4-Methylbenzyl bromide 
• 141196-28-3 trimethyl(((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)-tetrahydro-2H-pyran-2-yl)ethynyl)silane 
• 59531-24-7 2,3,4,6-tetra-O-benzyl-D-glucopyranoside 
• 17271-89-5 4-methylphenylmethylazide 
• 168105-32-6 4,5,6,8-tetra-O-acetyl-3,7-anhydro-1,1,2,2-tetradehydro-1,2-dideoxy-D-glycero-D-gulo-octitol 
• 13096-62-3 (3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-one 

Downstream Products

• 1355034-76-2 C₁₆H₂₁N₃O₅ 

Relevant academic research and scientific papers

Facile synthesis of 1,2,3-triazole analogs of SGLT2 inhibitors by 'click chemistry'

Novel analogs of SGLT2 inhibitors containing the 1,2,3-triazole motif were designed and synthesized for urinary glucose excretion evaluation. The C-glucosides with triazole aglycone can be easily constructed by click chemistry. Most of the synthesized compounds increased urinary glucose excretion and demonstrated inhibition of glucose transport.